Nakajima H - Search Results

1

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

Nakajima H, Kim YB, Terano H, Yoshida M, Horinouchi S. Nakajima H, et al. Exp Cell Res. 1998 May 25;241(1):126-33. doi: 10.1006/excr.1998.4027. Exp Cell Res. 1998. PMID: 9633520

2

Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A.

Hoshimoto A, Suzuki Y, Katsuno T, Nakajima H, Saito Y. Hoshimoto A, et al. Among authors: nakajima h. Br J Pharmacol. 2002 May;136(2):280-6. doi: 10.1038/sj.bjp.0704719. Br J Pharmacol. 2002. PMID: 12010777 Free PMC article.

3

Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility.

Durum SK, Candèias S, Nakajima H, Leonard WJ, Baird AM, Berg LJ, Muegge K. Durum SK, et al. Among authors: nakajima h. J Exp Med. 1998 Dec 21;188(12):2233-41. doi: 10.1084/jem.188.12.2233. J Exp Med. 1998. PMID: 9858510 Free PMC article.

4

Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism.

Suzuki K, Nakajima H, Kagami S, Suto A, Ikeda K, Hirose K, Hiwasa T, Takeda K, Saito Y, Akira S, Iwamoto I. Suzuki K, et al. Among authors: nakajima h. J Exp Med. 2002 Jul 1;196(1):27-38. doi: 10.1084/jem.20011682. J Exp Med. 2002. PMID: 12093868 Free PMC article.

5

IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells.

Suzuki K, Nakajima H, Ikeda K, Maezawa Y, Suto A, Takatori H, Saito Y, Iwamoto I. Suzuki K, et al. Among authors: nakajima h. J Exp Med. 2003 Dec 1;198(11):1717-27. doi: 10.1084/jem.20031701. Epub 2003 Nov 24. J Exp Med. 2003. PMID: 14638848 Free PMC article.

6

Stat5a inhibits IL-12-induced Th1 cell differentiation through the induction of suppressor of cytokine signaling 3 expression.

Takatori H, Nakajima H, Kagami S, Hirose K, Suto A, Suzuki K, Kubo M, Yoshimura A, Saito Y, Iwamoto I. Takatori H, et al. Among authors: nakajima h. J Immunol. 2005 Apr 1;174(7):4105-12. doi: 10.4049/jimmunol.174.7.4105. J Immunol. 2005. PMID: 15778369

7

Role of common cytokine receptor gamma chain (gamma(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells.

Suzuki K, Nakajima H, Watanabe N, Kagami Si, Suto A, Saito Y, Saito T, Iwamoto I. Suzuki K, et al. Among authors: nakajima h. Blood. 2000 Sep 15;96(6):2172-80. Blood. 2000. PMID: 10979963

8

IgE-dependent enhancement of Th2 cell-mediated allergic inflammation in the airways.

Maezawa Y, Nakajima H, Seto Y, Suto A, Kumano K, Kubo S, Karasuyama H, Saito Y, Iwamoto I. Maezawa Y, et al. Among authors: nakajima h. Clin Exp Immunol. 2004 Jan;135(1):12-8. doi: 10.1111/j.1365-2249.2004.02337.x. Clin Exp Immunol. 2004. PMID: 14678259 Free PMC article.

9

Development and characterization of IL-21-producing CD4+ T cells.

Suto A, Kashiwakuma D, Kagami S, Hirose K, Watanabe N, Yokote K, Saito Y, Nakayama T, Grusby MJ, Iwamoto I, Nakajima H. Suto A, et al. Among authors: nakajima h. J Exp Med. 2008 Jun 9;205(6):1369-79. doi: 10.1084/jem.20072057. Epub 2008 May 12. J Exp Med. 2008. PMID: 18474630 Free PMC article.

10

AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.

Saito Y, Kagami S, Sanayama Y, Ikeda K, Suto A, Kashiwakuma D, Furuta S, Iwamoto I, Nonaka K, Ohara O, Nakajima H. Saito Y, et al. Among authors: nakajima h. Arthritis Rheumatol. 2014 May;66(5):1185-94. doi: 10.1002/art.38324. Arthritis Rheumatol. 2014. PMID: 24782182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results